PUMA BIOTECHNOLOGY, INC. Research And Development Expense

Quick Answer

PUMA BIOTECHNOLOGY, INC. reported Research And Development Expense of $71.87 million for the year ending 2021.

  • PUMA BIOTECHNOLOGY, INC. showed a decrease of -26.4% in Research And Development Expense from 2020 to 2021.
  • This data is from PUMA BIOTECHNOLOGY, INC.'s annual report (Form 10-K), filed with the SEC on March 3, 2022.
  • XBRL data for this metric is available from 2011 to 2021 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 11 years of available data (2011 to 2021), PUMA BIOTECHNOLOGY, INC.'s Research And Development Expense has grown by 8,601.0%.
  • Historical annual values: Fiscal year 2021: $71.87 million | Fiscal year 2020: $97.65 million | Fiscal year 2019: $132.85 million | Fiscal year 2018: $164.85 million | Fiscal year 2017: $207.81 million | Fiscal year 2016: $222.80 million | Fiscal year 2015: $208.47 million | Fiscal year 2014: $122.92 million | Fiscal year 2013: $45.05 million | Fiscal year 2012: $49.64 million | Fiscal year 2011: $826.0 thousand.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: